Causes of Death in Follicular Lymphoma: a Single Center Retrospective Analysis
NCT02951871 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 237
Last updated 2016-11-09
Summary
Background.Although the life expectancy of patients with FL has recently increased, notably since the introduction of rituximab in combination with chemotherapy, little is known regarding the precise causes of patients death. Patients and methods'. This study describes the different causes of death in FL patients among followed since 2000 at Lyon University Hospital, centre Léon Bérard and Mayo Clinic. The causes of death will be classified as related to lymphoma progression, treatment-related toxicity (including TRM and secondary myelodysplastic syndrome/acute myeloid leukemia), secondary neoplasias, or other.
Conditions
- This Study Describes the Different Causes of Death in 237 FL Patients
Sponsors & Collaborators
-
Hospices Civils de Lyon
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2000-01-31
- Primary Completion
- 2016-01-31
- Completion
- 2016-07-31
Countries
- France
Study Locations
More Related Trials
-
Refractory Diffuse Large B-cell Lymphoma
NCT03664336 ·Status: COMPLETED
-
Molecular Prognosis of Lymphomas of the Central Nervous System (ALYCE-molecular)
NCT03859544 ·Status: UNKNOWN
-
Fludarabine, Mitoxantrone and Rituximab in Relapsed or Primary Failing Advanced Follicular Non-Hodgkin's Lymphoma
NCT00169208 ·Status: COMPLETED ·Phase: PHASE2
-
EBV-associated Diffuse Large B Cell Lymphoma
NCT03378947 ·Status: COMPLETED
-
Non-Hodgkin Lymphoma in Elderly Patients Above the Age of 80 in the Rituximab Era
NCT00902434 ·Status: COMPLETED
-
A Study of MabThera/Rituxan (Rituximab) in Patients With Non-Bulky Follicular Non-Hodgkin's Lymphoma
NCT01392716 ·Status: COMPLETED ·Phase: PHASE2
-
Rituximab in Treating Patients With Follicular Non-Hodgkin's Lymphoma
NCT00227695 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of BKM120 in Relapsed and Refractory NHL
NCT01693614 ·Status: COMPLETED ·Phase: PHASE2
-
Combined Rituximab and Lenalidomide Treatment for Untreated Patients With Follicular Lymphoma
NCT01476787 ·Status: COMPLETED ·Phase: PHASE3
-
Transplantation After Complete Response In Patients With T-cell Lymphoma
NCT05444712 ·Status: RECRUITING ·Phase: NA
-
Study of the Pronostic Impact of Immunohistochemical, Histological and Radiological Factors in Patients With Primary Central Nervous System Lymphoma.
NCT05347511 ·Status: UNKNOWN
-
Quality Of Life On Elderly Patients With Low Grade Non-Hodgkin Lymphoma
NCT05524298 ·Status: RECRUITING
-
Study of Prognosis of Follicular Lymphoma Through a Prospective Collection of Data (F2-study)
NCT01250223 ·Status: COMPLETED
-
Quality of Life in Lymphoma Patients One Year Post-chemotherapy
NCT04187118 ·Status: UNKNOWN
-
Rituximab and Involved Field Radiotherapy in Early Stage Follicular Lymphoma
NCT00509184 ·Status: COMPLETED ·Phase: PHASE2
-
Retrospective Analysis of Rituximab-containing Immunochemotherapy for Burkitt's or Burkitt-like Lymphoma in Adults
NCT01809600 ·Status: COMPLETED
-
Mediastinal Grey Zone Lymphoma From the LYSA
NCT03037177 ·Status: COMPLETED
-
Assessment of Survival and Autonomy With Rituximab Plus Chemotherapy or Rituximab Plus Lenalidomide for Elderly Patients With Relapsed Diffuse Large B-cell Lymphoma
NCT04113226 ·Status: UNKNOWN ·Phase: PHASE2
-
Study of Prognostic Factors in Adult Lymphoblastic Lymphoma
NCT03571997 ·Status: UNKNOWN
-
Phase III Study of SyB L-0501 in Combination With Rituximab to Treat Recurrent/Relapsed Diffuse Large B-Cell Lymphoma
NCT03372837 ·Status: COMPLETED ·Phase: PHASE3
-
Study of SyB L-0501 in Combination With Rituximab to Treat Relapsed/Refractory Diffuse Large B-Cell Lymphoma
NCT01118845 ·Status: COMPLETED ·Phase: PHASE2
-
Assessment of the Minimal Residual Disease in DLBCL From Cell-free Circulating DNA by NGS
NCT02339805 ·Status: COMPLETED ·Phase: NA
-
High-dose Intravenous Methotrexate Versus Intrathecal Methotrexate for Central Nervous System Prophylaxis in DLBCL
NCT03123718 ·Status: UNKNOWN ·Phase: PHASE3
-
Clinical Outcomes of Early-progressed Follicular Lymphoma in Korea
NCT04048395 ·Status: UNKNOWN
-
Real Time Molecular Characterization of Diffuse Large B Cell Lymphoma (DLBCL)
NCT03104478 ·Status: COMPLETED